Search
Showing results for "1"
Research
Progression of early structural lung disease in young children with cystic fibrosis assessed using CTCross-sectional studies implicate neutrophilic inflammation and pulmonary infection as risk factors for early structural lung disease in infants and young...
Research
The relationship between nutrition in infancy and cognitive performance during adolescenceNutrition in early childhood may have a long-term association with fundamental cognitive processing speed, which is likely to be related to enhanced brain...
News & Events
Research findings'Revisiting hypoglycaemia management in children with type 1 diabetes on contemporary therapy' survey results.
News & Events
PCH Schools visitOur head of epidemiology research Dr Aveni Haynes and exercise researcher Dr Wayne Soon were lucky enough to be invited to Perth Children’s Hospital School to discuss type 1 diabetes and the research we are doing here at the Children’s Diabetes Centre.
Research
Early versus late parenteral nutrition in term and late preterm infants: A randomised controlled trialThere is limited evidence regarding the optimal time to commence parenteral nutrition in term and late preterm infants.
News & Events
Join our nutrition videosWould you like to help teach others with diabetes? The team at the Rio Tinto Children’s Diabetes Centre are creating nutrition education videos for children and their parents living with type 1 diabetes.
News & Events
Research participation surveyWe recognise that we can learn a lot from our families. This area of research looks at the reasons why families living with diabetes choose whether or not to participate in research.
Research
Resilience and Diabetes 2 (the RAD2 study)Investigators: Anna Hunt, Ashleigh Lin Stress and anxiety are significant problems in children and adolescence with type 1 diabetes. Not only do
Research
Efficacy and Safety of Epicutaneous Immunotherapy in Peanut-Allergic Toddlers: Open-Label Extension to EPITOPEThe pivotal phase 3 EPITOPE trial, a 12-month, double-blind, placebo-controlled study of epicutaneous immunotherapy with the VIASKIN patch containing 250 μg of peanut protein (VP250), previously reported significant treatment response versus placebo in peanut-allergic toddlers aged 1 through 3 years.
Research
Control of mitophagy initiation and progression by the TBK1 adaptors NAP1 and SINTBADMitophagy preserves overall mitochondrial fitness by selectively targeting damaged mitochondria for degradation. The regulatory mechanisms that prevent PTEN-induced putative kinase 1 (PINK1) and E3 ubiquitin ligase Parkin (PINK1/Parkin)-dependent mitophagy and other selective autophagy pathways from overreacting while ensuring swift progression once initiated are largely elusive.